Pharmacy alerts

Isotretinoin – changes to prescribing guidance and additional risk minimisation measures

Drug Safety Update: CHM has endorsed changes to the risk minimisation measures for isotretinoin, following a review of the impact of the measures implemented in 2023.

Glenmark Pharmaceuticals Europe Limited, Fingolimod Glenmark 0.5 mg hard capsules recall

Class 3 medicines recall: The MHRA has published a Class 3 recall for Fingolimod Glenmark 0.5 mg hard capsules.

Mercury Pharmaceuticals Ltd, Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes recall

Class 2 medicines recall: The MHRA has published a Class 2 medicines recall for Paliperidone 50mg, 75mg, 100mg and 150mg prolonged-release suspension for injection in pre-filled syringes.

Epimax Ointment and Epimax Paraffin-Free Ointment – reports of ocular surface toxicity and ocular chemical injury

Drug Safety Update reminder: The MHRA is continuing to receive reports of ocular surface toxicity and ocular chemical injury for these emollients.

Steriflex® No. 109 (1L) and No. 171 (2L): potassium chloride 0.15%, sodium chloride 0.45%, glucose 2.5% bags supply

National Patient Safety Alert: The DHSC has published a National Patient Safety Alert regarding supply issues affecting products in the Steriflex® range.

Improving information supplied with gabapentinoids (pregabalin/gabapentin), benzodiazepines and z-drugs

Drug safety update: The MHRA has published a drug safety update following a review of the warnings accompanying gabapentin, pregabalin, benzodiazepines, and z-drugs.